Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Mama Bear who wrote (20174)	3/12/1999 3:58:00 PM
From: Doorman	Read Replies (1) \| Respond to of 122087

<ENMD> Hey Mama, What makes you think it's going higher? TIA

To: Mama Bear who wrote (20174)	3/12/1999 4:27:00 PM
From: M. LaMancha	Read Replies (1) \| Respond to of 122087

ENMD -- ANTHONY & MAMA -- PLEASE help me out here on DD. Maybe I screwed up. Main source of income is SBIR grants from NIH (royalties coming from thalidomide, which is not being widely used in cancer treatment -- OR AM I WRONG) and SBIR grants are limited with the idea that they are seed money to support eventual corporate sponsorship); Covance is a contract manufacturer getting paid -- not paying -- for the manufacture of Angiostatin (if and when it is made). Loss went from $6M to $13M last year on huge jump in G&A. Clinical trials have not yet begun (OR HAVE THEY????) Burn rate will skyrocket with the start of clinicals. Who will pay for this -- is there a sugar daddy I don't know about? I AM NOT TALKING "FEEL GOOD" HERE -- I really would appreciate someone to tell me where I am wrong so I can make a more informed judgment. HOW CAN THEY AFFORD CLINICAL TRIALS? I'm assuming Folkman will do them -- but hey, if this compound is so fragile that he has to bring NCI to his lab to do mouse work, how can clinical trials be done with any consistency? Anthony -- I'm tempted to hit this thing at the open with another 25%. What do you think?